Journal article icon

Journal article

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

Abstract:
Background Separating antibody-negative neuromyelitis optica spectrum disorders (NMOSD) from multiple sclerosis (MS) in borderline cases is extremely challenging due to lack of biomarkers. Elucidating different pathologies within the likely heterogenous antibody-negative NMOSD/MS overlap syndrome is, therefore, a major unmet need which would help avoid disability from inappropriate treatment. Objective In this study we aimed to identify distinct subgroups within the antibody-negative NMOSD/MS overlap syndrome. Methods Twenty-five relapsing antibody-negative patients with NMOSD features underwent a prospective brain and spinal cord MRI. Subgroups were identified by an unsupervised algorithm based on pre-selected NMOSD/MS discriminators. Results Four subgroups were identified. Patients from Group 1 termed "MS-like" (n = 6) often had central vein sign and cortical lesions (83% and 67%, respectively). All patients from Group 2 ("spinal MS-like", 8) had short-segment myelitis and no MS-like brain lesions. Group 3 ("classic NMO-like", 6) had high percentage of bilateral optic neuritis and longitudinally extensive transverse myelitis (LETM, 80% and 60%, respectively) and normal brain appearance (100%). Group 4 ("NMO-like with brain involvement", 5) typically had a history of NMOSD-like brain lesions and LETM. When compared with other groups, Group 4 had significantly decreased fractional anisotropy in non-lesioned tracts (0.46 vs. 0.49, p = 0.003) and decreased thalamus volume (0.84 vs. 0.98, p = 0.04). Conclusions NMOSD/MS cohort contains distinct subgroups likely corresponding to different pathologies and requiring tailored treatment. We propose that non-conventional MRI might help optimise diagnosis in these challenging patients
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/s00415-021-10619-1

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-5081-9677
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-1219-0062
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-8249-4723
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3965-9649
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-5698-4630


More from this funder
Funder identifier:
10.13039/501100006149
Grant:
A20069


Publisher:
Springer
Journal:
Journal of Neurology More from this journal
Volume:
269
Issue:
1
Pages:
269-279
Publication date:
2021-05-27
DOI:
EISSN:
1432-1459
ISSN:
0340-5354


Language:
English
Keywords:
Pubs id:
1179444
Local pid:
pubs:1179444
Source identifiers:
W3165699103
Deposit date:
2026-03-24
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP